Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders

Name: Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders
SKU: 2693
Price: 30.00 USD
Availability: InStock

$30.00

Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders

By Charles B. Nemeroff, MD, PhD

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Category: VOL 38 Supplement No. 1 Tags: adolescents, anxiety-disorders, charles-b-nemeroff, children, corticotropin-releasing-factor, crf-dysregulation, early-life-adversity, mood-disorders, physical-abuse, risk, sexual-abuse

Description

Description

Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders

By Charles B. Nemeroff, MD, PhD

014-020_otsuk…_Nemeroff.qxd_-1

Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders

Description

David V. Sheehan, MD, MBA: Current Approaches to the Pharmacologic Treatment of Anxiety Disorders

A Major Change of Prescribing Pattern in Absence of Adequate Evidence: Benzodiazepines Versus Newer Antidepressants in Anxiety Disorders

Long-Term Antidepressant Treatment

Remission as the Critical Outcome of Depression Treatment

Title

Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders

Description

Related products

David V. Sheehan, MD, MBA: Current Approaches to the Pharmacologic Treatment of Anxiety Disorders

A Major Change of Prescribing Pattern in Absence of Adequate Evidence: Benzodiazepines Versus Newer Antidepressants in Anxiety Disorders

Long-Term Antidepressant Treatment

Remission as the Critical Outcome of Depression Treatment

Title